AKR1B10 and malignant colon neoplasm: Our study purposes to discover the potent aldo-keto reductase inhibitors that may help to synthesize effective molecule with drug-likeness for the treatment of colon cancer specifically occur from the abnormal expression of either protein AKR1B1 or AKR1B10.